CSIMarket Company Name, Ticker, Competitors, else..
 
• P/E Ratio TTM
• P/S Ratio TTM
• P/CF Ratio TTM
• P/FCF Ratio TTM
• Price to Book MRQ
• Price to Tangible Book

Panbela Therapeutics Inc   (PBLA)
Other Ticker:  
 
 


Learn more about PBLA >> See PBLA Cash Flow >> Go back to PBLA Valuation Comparisons

PBLA Price to Cash Flow Ratio (Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Cash Flow Trailing 12 Months II. Quarter I. Quarter IV. Quarter III. Quarter II. Quarter
Price to Cash Flow (TTM) Ratio current            0.21            0.21            0.21            0.21            0.21
Cashflow TTM Y / Y Change - % - % - % - % - %
Cashflow Y / Y Change - % - % - % 21.78 % - %
Stock performance to date 188.55 % -63.4 % 1201.59 % -90.04 % -31.11 %

Price to Cash Flow ratio Comment
Due to increase in Cash flow in II. Quarter, Panbela Therapeutics Inc 's current Price to Cash Flow ratio is at 0.21.


What is Price to Cash Flow Ratio?
Valuation in Major Pharmaceutical Preparations Industry

Price to Cash Flow ratio Company Ranking
Within: No.
Industry #9
Sector #24
S&P 500 #131






Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com